Joetsu, Japan

Kazumichi Jo

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kazumichi Jo: Innovator in Heterocyclic Derivatives

Introduction

Kazumichi Jo is a notable inventor based in Joetsu, Japan. He has made significant contributions to the field of chemistry, particularly in the development of heterocyclic derivatives. With a total of 4 patents to his name, Jo continues to push the boundaries of innovation in his area of expertise.

Latest Patents

Kazumichi Jo's latest patents include a remarkable invention titled "Salt of fused heterocyclic derivative and crystal thereof." This invention provides a choline salt of 3-[2-fluoro-5-(2,3-difluoro-6-methoxybenzyl-oxy)-4-methoxyphenyl]-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid, which exhibits excellent solubility and storage stability. This innovative approach has the potential to enhance the effectiveness of pharmaceutical applications.

Career Highlights

Kazumichi Jo is currently associated with Kissei Pharmaceutical Co., Ltd., where he applies his expertise in developing new chemical compounds. His work has been instrumental in advancing the company's research and development initiatives. Jo's dedication to innovation has positioned him as a key player in the pharmaceutical industry.

Collaborations

Kazumichi Jo collaborates with Hideki Takeuchi, a fellow innovator in the field. Their combined efforts contribute to the ongoing research and development projects at Kissei Pharmaceutical Co., Ltd.

Conclusion

Kazumichi Jo's contributions to the field of heterocyclic derivatives exemplify his commitment to innovation and excellence. His patents reflect a deep understanding of chemistry and its applications in pharmaceuticals. Through his work, Jo continues to make a significant impact in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…